Evidence map›Paper›PMID 19546237›Full record

ArticleMolecular and cellular biology2009

TOR complex 2 controls gene silencing, telomere length maintenance, and survival under DNA-damaging conditions.

Miriam Schonbrun, Dana Laor, Luis López-Maury, Jürg Bähler, Martin Kupiec, Ronit Weisman

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. The TOR pathway modulates cytoophidium formation inThe Journal of biological chemistry · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Express yourself: how PP2A-B55Current genetics · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Miriam SchonbrunDepartment of Molecular Microbiology and Biotechnology, Tel-Aviv University, Tel-Aviv, Israel.
Dana Laor
Luis López-Maury
Jürg Bähler
Martin Kupiec
Ronit Weisman
Tel Aviv University · ILUniversity College London · GB

Funding

Cancer Research UKWorldwide Cancer Research 08-0070
6 · The paper itself

Abstract

The Target Of Rapamycin (TOR) kinase belongs to the highly conserved eukaryotic family of phosphatidylinositol-3-kinase-related kinases (PIKKs). TOR proteins are found at the core of two distinct evolutionarily conserved complexes, TORC1 and TORC2. Disruption of TORC1 or TORC2 results in characteristically dissimilar phenotypes. TORC1 is a major cell growth regulator, while the cellular roles of TORC2 are not well understood. In the fission yeast Schizosaccharomyces pombe, Tor1 is a component of the TORC2 complex, which is particularly required during starvation and various stress conditions. Our genome-wide gene expression analysis of Deltator1 mutants indicates an extensive similarity with chromatin structure mutants. Consistently, TORC2 regulates several chromatin-mediated functions, including gene silencing, telomere length maintenance, and tolerance to DNA damage. These novel cellular roles of TORC2 are rapamycin insensitive. Cells lacking Tor1 are highly sensitive to the DNA-damaging drugs hydroxyurea (HU) and methyl methanesulfonate, similar to mutants of the checkpoint kinase Rad3 (ATR). Unlike Rad3, Tor1 is not required for the cell cycle arrest in the presence of damaged DNA. Instead, Tor1 becomes essential for dephosphorylation and reactivation of the cyclin-dependent kinase Cdc2, thus allowing reentry into mitosis following recovery from DNA replication arrest. Taken together, our data highlight critical roles for TORC2 in chromatin metabolism and in promoting mitotic entry, most notably after recovery from DNA-damaging conditions. These data place TOR proteins in line with other PIKK members, such as ATM and ATR, as guardians of genome stability.

Indexed as

DNA DamageGene SilencingCDC2 Protein KinaseCell SurvivalDNA ReplicationEnzyme ActivationGene Expression Regulation, FungalHydroxyureaMethyl MethanesulfonateMitosisMultiprotein ComplexesMutagensNucleic Acid Synthesis InhibitorsOligonucleotide Array Sequence AnalysisProtein KinasesSchizosaccharomycesCDC2 Protein Kinasecdc2 protein, S pombeHydroxyureaMethyl MethanesulfonateMultiprotein ComplexesMutagensNucleic Acid Synthesis InhibitorsProtein KinasesSchizosaccharomyces pombe ProteinsTor1 protein, S pombe

Identifiers

PMID19546237
PMCPMC2725747
OpenAlexW1984949624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.